Publications
588 found
Show per page
Riboni-Verri, G., McMurran, C., Kuhle, J., Hofer, L., Coles, A., Brown, W., Needham, E., & Cunniffe, N. G. (2025). Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis [Journal-article]. Multiple Sclerosis and Related Disorders, 103. https://doi.org/10.1016/j.msard.2025.106655
Riboni-Verri, G., McMurran, C., Kuhle, J., Hofer, L., Coles, A., Brown, W., Needham, E., & Cunniffe, N. G. (2025). Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis [Journal-article]. Multiple Sclerosis and Related Disorders, 103. https://doi.org/10.1016/j.msard.2025.106655
Yaldizli, Özgür, Benkert, Pascal, Achtnichts, Lutz, Bar-Or, Amit, Bohner-Lang, Viviane, Bridel, Claire, Comabella, Manuel, Findling, Oliver, Disanto, Giulio, Finkener, Sebastian, Gobbi, Claudio, Granziera, Cristina, Herwerth, Marina, Hoepner, Robert, Horakova, Dana, Kamber, Nicole, Khalil, Michael, Kunz, Philipp, Lalive, Patrice, et al. (2025). Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. Multiple Sclerosis Journal, 31(8), 932–943. https://doi.org/10.1177/13524585251335466
Yaldizli, Özgür, Benkert, Pascal, Achtnichts, Lutz, Bar-Or, Amit, Bohner-Lang, Viviane, Bridel, Claire, Comabella, Manuel, Findling, Oliver, Disanto, Giulio, Finkener, Sebastian, Gobbi, Claudio, Granziera, Cristina, Herwerth, Marina, Hoepner, Robert, Horakova, Dana, Kamber, Nicole, Khalil, Michael, Kunz, Philipp, Lalive, Patrice, et al. (2025). Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. Multiple Sclerosis Journal, 31(8), 932–943. https://doi.org/10.1177/13524585251335466
Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, et al. (2025). Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 82(6), 614–625. https://doi.org/10.1001/jamaneurol.2025.0495
Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, et al. (2025). Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 82(6), 614–625. https://doi.org/10.1001/jamaneurol.2025.0495
Greselin, Martina, Lu, Po-Jui, Mroczek, Magdalena, Cerdá-Fuertes, Nuria, Demirtzoglou, Anastasios, Papadopoulou, Athina, , Leppert, David, Arnould, Sophie, Aoun, Manar, Kappos, Ludwig, Granziera, Cristina, & D’Souza, Marcus. (2025). AI-assisted identification of disability patterns within identical EDSS grades. Multiple Sclerosis Journal, 31(6), 677–688. https://doi.org/10.1177/13524585251327300
Greselin, Martina, Lu, Po-Jui, Mroczek, Magdalena, Cerdá-Fuertes, Nuria, Demirtzoglou, Anastasios, Papadopoulou, Athina, , Leppert, David, Arnould, Sophie, Aoun, Manar, Kappos, Ludwig, Granziera, Cristina, & D’Souza, Marcus. (2025). AI-assisted identification of disability patterns within identical EDSS grades. Multiple Sclerosis Journal, 31(6), 677–688. https://doi.org/10.1177/13524585251327300
Lim Falk, V., Mueller-Wirth, N., Karathanasis, D., Evangelopoulos, M. E., Maleska Maceski, A., Zadic, A., Kuhle, J., Schlup, C., Marti, S., Guse, K., Chan, A., & Pernet, V. (2025). Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 12(4). https://doi.org/10.1212/nxi.0000000000200404
Lim Falk, V., Mueller-Wirth, N., Karathanasis, D., Evangelopoulos, M. E., Maleska Maceski, A., Zadic, A., Kuhle, J., Schlup, C., Marti, S., Guse, K., Chan, A., & Pernet, V. (2025). Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 12(4). https://doi.org/10.1212/nxi.0000000000200404
Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Horakova, Dana, Kubala Havrdova, Eva, Eichau, Sara, Patti, Francesco, Grammond, Pierre, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Grand’Maison, Francois, Alroughani, Raed, Lechner-Scott, Jeannette, Spitaleri, Daniele, Barnett, Michael, Cartechini, Elisabetta, Sa, Maria Jose, et al. (2025). Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study. CNS Drugs, 39(4), 403–416. https://doi.org/10.1007/s40263-025-01164-w
Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Horakova, Dana, Kubala Havrdova, Eva, Eichau, Sara, Patti, Francesco, Grammond, Pierre, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Grand’Maison, Francois, Alroughani, Raed, Lechner-Scott, Jeannette, Spitaleri, Daniele, Barnett, Michael, Cartechini, Elisabetta, Sa, Maria Jose, et al. (2025). Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study. CNS Drugs, 39(4), 403–416. https://doi.org/10.1007/s40263-025-01164-w
Mondesert, E., Delaby, C., De La Cruz, E., Kuhle, J., Benkert, P., Pradeilles, N., Duchiron, M., Morchikh, M., Camu, W., Cristol, J.-P., Hirtz, C., Esselin, F., & Lehmann, S. (2025). Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis [Journal-article]. Neurology, 104(6). https://doi.org/10.1212/wnl.0000000000213400
Mondesert, E., Delaby, C., De La Cruz, E., Kuhle, J., Benkert, P., Pradeilles, N., Duchiron, M., Morchikh, M., Camu, W., Cristol, J.-P., Hirtz, C., Esselin, F., & Lehmann, S. (2025). Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis [Journal-article]. Neurology, 104(6). https://doi.org/10.1212/wnl.0000000000213400
Oechtering, Johanna, Schaedelin, Sabine Anna, Stein, Kerstin, Maceski, Aleksandra Maleska, Melie-Garcia, Lester, Benkert, Pascal, Cagol, Alessandro, Leber, Selina, Galbusera, Riccardo, Ruberte, Esther, Hu, Wayne, Qureshi, Ferhan, Orleth, Annette, Demuth, Lilian, Willemse, Eline, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias J., Fischer-Barnicol, Bettina, et al. (2025). Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 12(2). https://doi.org/10.1212/nxi.0000000000200361
Oechtering, Johanna, Schaedelin, Sabine Anna, Stein, Kerstin, Maceski, Aleksandra Maleska, Melie-Garcia, Lester, Benkert, Pascal, Cagol, Alessandro, Leber, Selina, Galbusera, Riccardo, Ruberte, Esther, Hu, Wayne, Qureshi, Ferhan, Orleth, Annette, Demuth, Lilian, Willemse, Eline, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias J., Fischer-Barnicol, Bettina, et al. (2025). Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 12(2). https://doi.org/10.1212/nxi.0000000000200361
Benkert, Pascal, Maleska Maceski, Aleksandra, Schaedelin, Sabine, Oechtering, Johanna, Zadic, Amar, Vilchez Gomez, Juan Francisco, Melie‐Garcia, Lester, Cagol, Alessandro, Galbusera, Riccardo, Subramaniam, Suvitha, Lorscheider, Johannes, Galli, Edoardo, Mueller, Jannis, Fischer‐Barnicol, Bettina, Achtnichts, Lutz, Findling, Oliver, Lalive, Patrice H., Bridel, Claire, Uginet, Marjolaine, et al. (2025). Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis. Annals of Neurology, 97(1), 104–115. https://doi.org/10.1002/ana.27096
Benkert, Pascal, Maleska Maceski, Aleksandra, Schaedelin, Sabine, Oechtering, Johanna, Zadic, Amar, Vilchez Gomez, Juan Francisco, Melie‐Garcia, Lester, Cagol, Alessandro, Galbusera, Riccardo, Subramaniam, Suvitha, Lorscheider, Johannes, Galli, Edoardo, Mueller, Jannis, Fischer‐Barnicol, Bettina, Achtnichts, Lutz, Findling, Oliver, Lalive, Patrice H., Bridel, Claire, Uginet, Marjolaine, et al. (2025). Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis. Annals of Neurology, 97(1), 104–115. https://doi.org/10.1002/ana.27096
Disanto, Giulio, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Galbusera, Riccardo, Finkener, Sebastian, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Hoepner, Robert, Salmen, Anke, Zecca, Chiara, Hemkens, Lars G, D’Souza, Marcus, Fischer-Barnicol, Bettina, Du Pasquier, Renaud, Roth, Patrick, Yaldizli, Özgür, et al. (2025). Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 11(1). https://doi.org/10.1177/20552173251315457
Disanto, Giulio, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Galbusera, Riccardo, Finkener, Sebastian, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Hoepner, Robert, Salmen, Anke, Zecca, Chiara, Hemkens, Lars G, D’Souza, Marcus, Fischer-Barnicol, Bettina, Du Pasquier, Renaud, Roth, Patrick, Yaldizli, Özgür, et al. (2025). Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 11(1). https://doi.org/10.1177/20552173251315457
Sjöros, T., Saraste, M., Matilainen, M., Nylund, M., Koivumäki, M., Kuhle, J., Leppert, D., & Airas, L. (2025). Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain [Journal-article]. Therapeutic Advances in Neurological Disorders, 18. https://doi.org/10.1177/17562864251352998
Sjöros, T., Saraste, M., Matilainen, M., Nylund, M., Koivumäki, M., Kuhle, J., Leppert, D., & Airas, L. (2025). Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain [Journal-article]. Therapeutic Advances in Neurological Disorders, 18. https://doi.org/10.1177/17562864251352998
Zhu, C., Zhou, Z., Kalincik, T., Roos, I., Buzzard, K., Skibina, O., Alroughani, R., Kuhle, J., Girard, M., Grammond, P., Lechner-Scott, J., Gerlach, O., John, N., McCombe, P., Macdonell, R., van Pesch, V., Laureys, G., Prevost, J., Horakova, D., et al. (2025). Persistent progression independent of relapse activity in multiple sclerosis [Journal-article]. Brain Communications, 7. https://doi.org/10.1093/braincomms/fcaf306
Zhu, C., Zhou, Z., Kalincik, T., Roos, I., Buzzard, K., Skibina, O., Alroughani, R., Kuhle, J., Girard, M., Grammond, P., Lechner-Scott, J., Gerlach, O., John, N., McCombe, P., Macdonell, R., van Pesch, V., Laureys, G., Prevost, J., Horakova, D., et al. (2025). Persistent progression independent of relapse activity in multiple sclerosis [Journal-article]. Brain Communications, 7. https://doi.org/10.1093/braincomms/fcaf306
Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, , Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article]. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6
Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, , Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article]. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25. https://doi.org/10.1186/s13063-024-08454-6
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25. https://doi.org/10.1186/s13063-024-08454-6
Sehr, Tony, Akgün, Katja, Benkert, Pascal, , Ziemssen, Tjalf, & Brandt, Moritz D. (2024). Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance. Journal of Sleep Research, 33(5). https://doi.org/10.1111/jsr.14164
Sehr, Tony, Akgün, Katja, Benkert, Pascal, , Ziemssen, Tjalf, & Brandt, Moritz D. (2024). Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance. Journal of Sleep Research, 33(5). https://doi.org/10.1111/jsr.14164
Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, , Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/nxi.0000000000200299
Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, , Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/nxi.0000000000200299
Müller, Jannis, Lu, Po-Jui, Cagol, Alessandro, Ruberte, Esther, Shin, Hyeong-Geol, Ocampo-Pineda, Mario, Chen, Xinjie, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Weigel, Matthias, Schaedelin, Sabine A., Wang, Yi, Nguyen, Thanh D., Spincemaille, Pascal, Kappos, Ludwig, , Lee, Jongho, & Granziera, Cristina. (2024). Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions [Journal-article]. Neurology, 103(6). https://doi.org/10.1212/WNL.0000000000209604
Müller, Jannis, Lu, Po-Jui, Cagol, Alessandro, Ruberte, Esther, Shin, Hyeong-Geol, Ocampo-Pineda, Mario, Chen, Xinjie, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Weigel, Matthias, Schaedelin, Sabine A., Wang, Yi, Nguyen, Thanh D., Spincemaille, Pascal, Kappos, Ludwig, , Lee, Jongho, & Granziera, Cristina. (2024). Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions [Journal-article]. Neurology, 103(6). https://doi.org/10.1212/WNL.0000000000209604
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, , Bouzigues, Arabella, Russell, Lucy L, Foster, Phoebe H, Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C, Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, , Bouzigues, Arabella, Russell, Lucy L, Foster, Phoebe H, Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C, Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, , Bouzigues, Arabella, Russell, Lucy L., Foster, Phoebe H., Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C., Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert Jr, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, , Bouzigues, Arabella, Russell, Lucy L., Foster, Phoebe H., Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C., Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert Jr, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
Roos, I., Sharmin, S., Malpas, C., Ozakbas, S., Lechner-Scott, J., Hodgkinson, S., Alroughani, R., Eichau Madueño, S., Boz, C., van der Walt, A., Butzkueven, H., Buzzard, K., Skibina, O., Foschi, M., Grand’Maison, F., John, N., Grammond, P., Terzi, M., Prévost, J., et al. (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30(9), 1163–1175. https://doi.org/10.1177/13524585241267211
Roos, I., Sharmin, S., Malpas, C., Ozakbas, S., Lechner-Scott, J., Hodgkinson, S., Alroughani, R., Eichau Madueño, S., Boz, C., van der Walt, A., Butzkueven, H., Buzzard, K., Skibina, O., Foschi, M., Grand’Maison, F., John, N., Grammond, P., Terzi, M., Prévost, J., et al. (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30(9), 1163–1175. https://doi.org/10.1177/13524585241267211
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F., & Ruprecht, K. (2024). Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort study. Multiple Sclerosis and Related Disorders, 88. https://doi.org/10.1016/j.msard.2024.105729
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F., & Ruprecht, K. (2024). Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort study. Multiple Sclerosis and Related Disorders, 88. https://doi.org/10.1016/j.msard.2024.105729
Zivadinov, R., Jakimovski, D., Burnham, A., Kuhle, J., Weinstock, Z., Wicks, T. R., Ramanathan, M., Sciortino, T., Ostrem, M., Suchan, C., Dwyer, M. G., Reilly, J., Bergsland, N., Schweser, F., Kennedy, C., Young-Hong, D., Eckert, S., Hojnacki, D., Benedict, R. H. B., & Weinstock-Guttman, B. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology, 271(8), 4949–4962. https://doi.org/10.1007/s00415-024-12420-2
Zivadinov, R., Jakimovski, D., Burnham, A., Kuhle, J., Weinstock, Z., Wicks, T. R., Ramanathan, M., Sciortino, T., Ostrem, M., Suchan, C., Dwyer, M. G., Reilly, J., Bergsland, N., Schweser, F., Kennedy, C., Young-Hong, D., Eckert, S., Hojnacki, D., Benedict, R. H. B., & Weinstock-Guttman, B. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology, 271(8), 4949–4962. https://doi.org/10.1007/s00415-024-12420-2
Chalkou, Konstantina, Hamza, Tasnim, Benkert, Pascal, , Zecca, Chiara, Simoneau, Gabrielle, Pellegrini, Fabio, Manca, Andrea, Egger, Matthias, & Salanti, Georgia. (2024). Combining randomized and non-randomized data to predict heterogeneous effects of competing treatments. Research Synthesis Methods, 15(4), 641–656. https://doi.org/10.1002/jrsm.1717
Chalkou, Konstantina, Hamza, Tasnim, Benkert, Pascal, , Zecca, Chiara, Simoneau, Gabrielle, Pellegrini, Fabio, Manca, Andrea, Egger, Matthias, & Salanti, Georgia. (2024). Combining randomized and non-randomized data to predict heterogeneous effects of competing treatments. Research Synthesis Methods, 15(4), 641–656. https://doi.org/10.1002/jrsm.1717
Zuo, Michelle, Fettig, Naomi M., Bernier, Louis-Philippe, Pössnecker, Elisabeth, Spring, Shoshana, Pu, Annie, Ma, Xianjie I., Lee, Dennis Sw, Ward, Lesley A., Sharma, Anshu, , Sled, John G., Pröbstel, Anne-Katrin, MacVicar, Brian A., Osborne, Lisa C., Gommerman, Jennifer L., & Ramaglia, Valeria. (2024). Erratum: Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation (JCI insight PII: e183445). JCI Insight, 9(12). https://doi.org/10.1172/jci.insight.183445
Zuo, Michelle, Fettig, Naomi M., Bernier, Louis-Philippe, Pössnecker, Elisabeth, Spring, Shoshana, Pu, Annie, Ma, Xianjie I., Lee, Dennis Sw, Ward, Lesley A., Sharma, Anshu, , Sled, John G., Pröbstel, Anne-Katrin, MacVicar, Brian A., Osborne, Lisa C., Gommerman, Jennifer L., & Ramaglia, Valeria. (2024). Erratum: Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation (JCI insight PII: e183445). JCI Insight, 9(12). https://doi.org/10.1172/jci.insight.183445
Signori, Alessio, Ponzano, Marta, Kalincik, Tomas, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Alroughani, Raed, Patti, Francesco, , Izquierdo, Guillermo, Eichau, Sara, Yamout, Bassem, Khoury, Samia Joseph, Karabudak, Rana, Grammond, Pierre, Duquette, Pierre, Roos, Izanne, Butzkueven, Helmut, van der Walt, Anneke, & Sormani, Maria Pia. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: An application using data from the MSBase Registry. Journal of Neurology, Neurosurgery and Psychiatry, 95(7), 620–625. https://doi.org/10.1136/jnnp-2023-332603
Signori, Alessio, Ponzano, Marta, Kalincik, Tomas, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Alroughani, Raed, Patti, Francesco, , Izquierdo, Guillermo, Eichau, Sara, Yamout, Bassem, Khoury, Samia Joseph, Karabudak, Rana, Grammond, Pierre, Duquette, Pierre, Roos, Izanne, Butzkueven, Helmut, van der Walt, Anneke, & Sormani, Maria Pia. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: An application using data from the MSBase Registry. Journal of Neurology, Neurosurgery and Psychiatry, 95(7), 620–625. https://doi.org/10.1136/jnnp-2023-332603
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C., & Kröger, N. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med, 5(6), 550–558. https://doi.org/10.1016/j.medj.2024.03.002
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C., & Kröger, N. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med, 5(6), 550–558. https://doi.org/10.1016/j.medj.2024.03.002
Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, , Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of Neurology, 271(6), 3131–3141. https://doi.org/10.1007/s00415-024-12366-5
Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, , Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of Neurology, 271(6), 3131–3141. https://doi.org/10.1007/s00415-024-12366-5
Maatta, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., Witte, D. R., & Jensen, T. S. (2024). Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2208
Maatta, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., Witte, D. R., & Jensen, T. S. (2024). Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2208
Fissolo, Nicolás, Benkert, Pascal, Sastre-Garriga, Jaume, Mongay-Ochoa, Neus, Vilaseca-Jolonch, Andreu, Llufriu, Sara, Blanco, Yolanda, Hegen, Harald, Berek, Klaus, Perez-Miralles, Francisco, Rejdak, Konrad, Villar, Luisa M., Monreal, Enric, Alvarez-Lafuente, Roberto, Soylu, Onder K., Abdelhak, Ahmed, Bachhuber, Franziska, Tumani, Hayrettin, Martínez-Yélamos, Sergio, et al. (2024). Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 95(5), 410–418. https://doi.org/10.1136/jnnp-2023-332251
Fissolo, Nicolás, Benkert, Pascal, Sastre-Garriga, Jaume, Mongay-Ochoa, Neus, Vilaseca-Jolonch, Andreu, Llufriu, Sara, Blanco, Yolanda, Hegen, Harald, Berek, Klaus, Perez-Miralles, Francisco, Rejdak, Konrad, Villar, Luisa M., Monreal, Enric, Alvarez-Lafuente, Roberto, Soylu, Onder K., Abdelhak, Ahmed, Bachhuber, Franziska, Tumani, Hayrettin, Martínez-Yélamos, Sergio, et al. (2024). Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 95(5), 410–418. https://doi.org/10.1136/jnnp-2023-332251
Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20(5), 269–287. https://doi.org/10.1038/s41582-024-00955-x
Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20(5), 269–287. https://doi.org/10.1038/s41582-024-00955-x
Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, , Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior, 14(5). https://doi.org/10.1002/brb3.3498
Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, , Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior, 14(5). https://doi.org/10.1002/brb3.3498
Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P., et al. (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. The Lancet Child and Adolescent Health, 8(5), 348–357. https://doi.org/10.1016/s2352-4642(24)00047-6
Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P., et al. (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. The Lancet Child and Adolescent Health, 8(5), 348–357. https://doi.org/10.1016/s2352-4642(24)00047-6
Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, , Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938
Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, , Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938
Montalban, Xavier, Piasecka-Stryczynska, Karolina, , Benkert, Pascal, Arnold, Douglas L, Weber, Martin S, Seitzinger, Andrea, Guehring, Hans, Shaw, Jamie, Tomic, Davorka, Hyvert, Yann, Harlow, Danielle E, Dyroff, Martin, & Wolinsky, Jerry S. (2024). Efficacy and safety results after > 3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple Sclerosis Journal, 30(4-5), 558–570. https://doi.org/10.1177/13524585241234783
Montalban, Xavier, Piasecka-Stryczynska, Karolina, , Benkert, Pascal, Arnold, Douglas L, Weber, Martin S, Seitzinger, Andrea, Guehring, Hans, Shaw, Jamie, Tomic, Davorka, Hyvert, Yann, Harlow, Danielle E, Dyroff, Martin, & Wolinsky, Jerry S. (2024). Efficacy and safety results after > 3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple Sclerosis Journal, 30(4-5), 558–570. https://doi.org/10.1177/13524585241234783
Queissner, R., Buchmann, A., Demjaha, R., Tafrali, C., Benkert, P., , Jerkovic, A., Dalkner, N., Fellendorf, F., Birner, A., Platzer, M., Tmava-Berisha, A., Maget, A., Stross, T., Lenger, M., Häussl, A., Khalil, M., & Reininghaus, E. (2024). Serum neurofilament light as a potential marker of illness duration in bipolar disorder. Journal of Affective Disorders, 350, 366–371. https://doi.org/10.1016/j.jad.2024.01.088
Queissner, R., Buchmann, A., Demjaha, R., Tafrali, C., Benkert, P., , Jerkovic, A., Dalkner, N., Fellendorf, F., Birner, A., Platzer, M., Tmava-Berisha, A., Maget, A., Stross, T., Lenger, M., Häussl, A., Khalil, M., & Reininghaus, E. (2024). Serum neurofilament light as a potential marker of illness duration in bipolar disorder. Journal of Affective Disorders, 350, 366–371. https://doi.org/10.1016/j.jad.2024.01.088
Spelman, T., Eichau, S., Alroughani, R., Ozakbas, S., Khoury, S. J., Patti, F., Kubala Havrdova, E., Boz, C., Terzi, M., Kuhle, J., Grammond, P., Lechner-Scott, J., Gray, O., Amato, M. P., Laureys, G., Shaygannejad, V., Hyde, R., Wang, H., Bozin, I., et al. (2024). Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10(2). https://doi.org/10.1177/20552173241247182
Spelman, T., Eichau, S., Alroughani, R., Ozakbas, S., Khoury, S. J., Patti, F., Kubala Havrdova, E., Boz, C., Terzi, M., Kuhle, J., Grammond, P., Lechner-Scott, J., Gray, O., Amato, M. P., Laureys, G., Shaygannejad, V., Hyde, R., Wang, H., Bozin, I., et al. (2024). Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10(2). https://doi.org/10.1177/20552173241247182
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720
Wang, Angela A., Luessi, Felix, Neziraj, Tradite, Pössnecker, Elisabeth, Zuo, Michelle, Engel, Sinah, Hanuscheck, Nicholas, Florescu, Alexandra, Bugbee, Eryn, Ma, Xianjie I., Rana, Fatima, Lee, Dennis, Ward, Lesley A., , Himbert, Johannes, Schraad, Muriel, van Puijenbroek, Erwin, Klein, Christian, Urich, Eduard, et al. (2024). B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans. Science Translational Medicine, 16(737). https://doi.org/10.1126/scitranslmed.adi0295
Wang, Angela A., Luessi, Felix, Neziraj, Tradite, Pössnecker, Elisabeth, Zuo, Michelle, Engel, Sinah, Hanuscheck, Nicholas, Florescu, Alexandra, Bugbee, Eryn, Ma, Xianjie I., Rana, Fatima, Lee, Dennis, Ward, Lesley A., , Himbert, Johannes, Schraad, Muriel, van Puijenbroek, Erwin, Klein, Christian, Urich, Eduard, et al. (2024). B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans. Science Translational Medicine, 16(737). https://doi.org/10.1126/scitranslmed.adi0295
Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, , Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5. Brain, 147(3), 839–848. https://doi.org/10.1093/brain/awad424
Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, , Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5. Brain, 147(3), 839–848. https://doi.org/10.1093/brain/awad424
Freedman, Mark S., Gnanapavan, Sharmilee, Booth, Ronald A., Calabresi, Peter A., Khalil, Michael, , Lycke, Jan, & Olsson, Tomas. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. eBioMedicine, 101. https://doi.org/10.1016/j.ebiom.2024.104970
Freedman, Mark S., Gnanapavan, Sharmilee, Booth, Ronald A., Calabresi, Peter A., Khalil, Michael, , Lycke, Jan, & Olsson, Tomas. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. eBioMedicine, 101. https://doi.org/10.1016/j.ebiom.2024.104970
Geis, T., Gutzeit, S., Disse, S., Kuhle, J., Fouzas, S., & Wellmann, S. (2024). Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders. Children, 11(3). https://doi.org/10.3390/children11030360
Geis, T., Gutzeit, S., Disse, S., Kuhle, J., Fouzas, S., & Wellmann, S. (2024). Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders. Children, 11(3). https://doi.org/10.3390/children11030360
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, , Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia. The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, , Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia. The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3
Abdelhak, Ahmed, Antweiler, Kai, Kowarik, Markus C., Senel, Makbule, Havla, Joachim, Zettl, Uwe K., Kleiter, Ingo, Skripuletz, Thomas, Haarmann, Axel, Stahmann, Alexander, Huss, Andre, Gingele, Stefan, Krumbholz, Markus, Benkert, Pascal, , Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Kümpfel, Tania, & Tumani, Hayrettin. (2024). Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis. Annals of Clinical and Translational Neurology, 11(2), 477–485. https://doi.org/10.1002/acn3.51969
Abdelhak, Ahmed, Antweiler, Kai, Kowarik, Markus C., Senel, Makbule, Havla, Joachim, Zettl, Uwe K., Kleiter, Ingo, Skripuletz, Thomas, Haarmann, Axel, Stahmann, Alexander, Huss, Andre, Gingele, Stefan, Krumbholz, Markus, Benkert, Pascal, , Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Kümpfel, Tania, & Tumani, Hayrettin. (2024). Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis. Annals of Clinical and Translational Neurology, 11(2), 477–485. https://doi.org/10.1002/acn3.51969
Hermesdorf, Marco, Wulms, Niklas, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Wiendl, Heinz, , & Berger, Klaus. (2024). Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis. GeroScience, 46(1), 463–472. https://doi.org/10.1007/s11357-023-00846-x
Hermesdorf, Marco, Wulms, Niklas, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Wiendl, Heinz, , & Berger, Klaus. (2024). Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis. GeroScience, 46(1), 463–472. https://doi.org/10.1007/s11357-023-00846-x
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Pontillo, G., Prados, F., Colman, J., Kanber, B., Abdel-Mannan, O., Al-Araji, S., Ballenberg, B., Bianchi, A., Bisecco, A., Brownlee, W., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Christensen, R., Cocozza, S., Colato, E., Collorone, S., Cortese, R., et al. (2024). Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.02.23300497
Pontillo, G., Prados, F., Colman, J., Kanber, B., Abdel-Mannan, O., Al-Araji, S., Ballenberg, B., Bianchi, A., Bisecco, A., Brownlee, W., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Christensen, R., Cocozza, S., Colato, E., Collorone, S., Cortese, R., et al. (2024). Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.02.23300497
Wilson, David, Chan, Dandan, Chang, Lei, Mathis, Robert, Verberk, Inge, Montalban, Xavier, Comabella, Manuel, Fissolo, Nicolas, Bielekova, Bibi, Masvekar, Ruturaj, Chitnis, Tanuja, Ziemssen, Tjalf, Akgün, Katja, Blennow, Kaj, Zetterberg, Henrik, Brück, Wolfgang, Giovannoni, Gavin, Gnanapavan, Sharmilee, Bittner, Stefan, et al. (2024). Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine, 62(2), 322–331. https://doi.org/10.1515/cclm-2023-0518
Wilson, David, Chan, Dandan, Chang, Lei, Mathis, Robert, Verberk, Inge, Montalban, Xavier, Comabella, Manuel, Fissolo, Nicolas, Bielekova, Bibi, Masvekar, Ruturaj, Chitnis, Tanuja, Ziemssen, Tjalf, Akgün, Katja, Blennow, Kaj, Zetterberg, Henrik, Brück, Wolfgang, Giovannoni, Gavin, Gnanapavan, Sharmilee, Bittner, Stefan, et al. (2024). Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine, 62(2), 322–331. https://doi.org/10.1515/cclm-2023-0518
Kagerer, Sonja M., Awasthi, Swapnil, Ripke, Stephan, Maceski, Aleksandra, Benkert, Pascal, Fall, Aïda B., Riederer, Peter, Fischer, Peter, Walitza, Susanne, Grünblatt, Edna, , & Unschuld, Paul G. (2024). Polygenic risk for Alzheimer’s disease is associated with neuroaxonal damage before onset of clinical symptoms. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 16(1). https://doi.org/10.1002/dad2.12504
Kagerer, Sonja M., Awasthi, Swapnil, Ripke, Stephan, Maceski, Aleksandra, Benkert, Pascal, Fall, Aïda B., Riederer, Peter, Fischer, Peter, Walitza, Susanne, Grünblatt, Edna, , & Unschuld, Paul G. (2024). Polygenic risk for Alzheimer’s disease is associated with neuroaxonal damage before onset of clinical symptoms. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 16(1). https://doi.org/10.1002/dad2.12504
Kuhle, J. (2024). Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241239101
Kuhle, J. (2024). Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241239101
Dekeyser, C., Hautekeete, M., Cambron, M., Van Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csepany, T., et al. (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-333307
Dekeyser, C., Hautekeete, M., Cambron, M., Van Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csepany, T., et al. (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-333307
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, , Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis. Neurology, 102(3), e207966. https://doi.org/10.1212/wnl.0000000000207966
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, , Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis. Neurology, 102(3), e207966. https://doi.org/10.1212/wnl.0000000000207966
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, , Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis [Journal-article]. Neurology, 102(3). https://doi.org/10.1212/wnl.0000000000207966
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, , Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis [Journal-article]. Neurology, 102(3). https://doi.org/10.1212/wnl.0000000000207966
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, , Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurology, 80(12), 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956
Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, , Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurology, 80(12), 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis [Journal-article]. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis [Journal-article]. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, , Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy. Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, , Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy. Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, , Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy [Journal-article]. Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, , Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy [Journal-article]. Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
Körtvelyessy, Peter, Diekämper, Elena, Ruprecht, Klemens, Endres, Matthias, Stubbemann, Paula, Kurth, Florian, Graw, Jan Adriaan, Menk, Mario, , & Wohlrab, Felix. (2023). Serum neurofilament light chain in COVID-19 and the influence of renal function. European Journal of Medical Research, 28(1). https://doi.org/10.1186/s40001-023-01375-1
Körtvelyessy, Peter, Diekämper, Elena, Ruprecht, Klemens, Endres, Matthias, Stubbemann, Paula, Kurth, Florian, Graw, Jan Adriaan, Menk, Mario, , & Wohlrab, Felix. (2023). Serum neurofilament light chain in COVID-19 and the influence of renal function. European Journal of Medical Research, 28(1). https://doi.org/10.1186/s40001-023-01375-1
Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, , Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis. European Journal of Neurology, 30(12), 3809–3818. https://doi.org/10.1111/ene.16044
Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, , Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis. European Journal of Neurology, 30(12), 3809–3818. https://doi.org/10.1111/ene.16044
Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, , & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study. Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01663-5
Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, , & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study. Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01663-5
Sy, Michael, Newton, Barbara L., Pawling, Judy, Hayama, Ken L., Cordon, Andres, Yu, Zhaoxia, , Dennis, James W., Brandt, Alexander U., & Demetriou, Michael. (2023). N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial. Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02893-9
Sy, Michael, Newton, Barbara L., Pawling, Judy, Hayama, Ken L., Cordon, Andres, Yu, Zhaoxia, , Dennis, James W., Brandt, Alexander U., & Demetriou, Michael. (2023). N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial. Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02893-9
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, , Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review. JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, , Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review. JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Rosenkranz, Sina C., Gutmann, Lilija, Has Silemek, Arzu Ceylan, Dorr, Michael, Häußler, Vivien, Lüpke, Margareta, Mönch, Andrea, Reinhardt, Stefanie, , Tilsley, Penelope, Heesen, Christoph, Friese, Manuel A., Brandt, Alexander, Paul, Friedemann, Zimmermann, Hanna, & Stellmann, Jan-Patrick. (2023). Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(11), 924–933. https://doi.org/10.1136/jnnp-2023-331183
Rosenkranz, Sina C., Gutmann, Lilija, Has Silemek, Arzu Ceylan, Dorr, Michael, Häußler, Vivien, Lüpke, Margareta, Mönch, Andrea, Reinhardt, Stefanie, , Tilsley, Penelope, Heesen, Christoph, Friese, Manuel A., Brandt, Alexander, Paul, Friedemann, Zimmermann, Hanna, & Stellmann, Jan-Patrick. (2023). Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(11), 924–933. https://doi.org/10.1136/jnnp-2023-331183
Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M., Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K., Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, et al. (2023). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain, 146(11), 4633–4644. https://doi.org/10.1093/brain/awad218
Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M., Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K., Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, et al. (2023). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain, 146(11), 4633–4644. https://doi.org/10.1093/brain/awad218
Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., , Kappos, L., Sanderson, N., & Derfuss, T. (2023). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121
Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., , Kappos, L., Sanderson, N., & Derfuss, T. (2023). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121
Uher, Tomas, Adzima, Adrian, Srpova, Barbora, Noskova, Libuse, Maréchal, Bénédicte, Maceski, Aleksandra Maleska, Krasensky, Jan, Stastna, Dominika, Andelova, Michaela, Novotna, Klara, Vodehnalova, Karolina, Motyl, Jiri, Friedova, Lucie, Lindner, Jiri, Ravano, Veronica, Burgetova, Andrea, Dusek, Petr, Fialova, Lenka, Havrdova, Eva Kubala, et al. (2023). Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Multiple Sclerosis Journal, 29(11-12), 1437–1451. https://doi.org/10.1177/13524585231197076
Uher, Tomas, Adzima, Adrian, Srpova, Barbora, Noskova, Libuse, Maréchal, Bénédicte, Maceski, Aleksandra Maleska, Krasensky, Jan, Stastna, Dominika, Andelova, Michaela, Novotna, Klara, Vodehnalova, Karolina, Motyl, Jiri, Friedova, Lucie, Lindner, Jiri, Ravano, Veronica, Burgetova, Andrea, Dusek, Petr, Fialova, Lenka, Havrdova, Eva Kubala, et al. (2023). Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Multiple Sclerosis Journal, 29(11-12), 1437–1451. https://doi.org/10.1177/13524585231197076
Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80(9), 989–995. https://doi.org/10.1001/jamaneurol.2023.2523
Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80(9), 989–995. https://doi.org/10.1001/jamaneurol.2023.2523
Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22(9), 826–833. https://doi.org/10.1016/s1474-4422(23)00210-7
Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22(9), 826–833. https://doi.org/10.1016/s1474-4422(23)00210-7
Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726
Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726
Leppert, David, Watanabe, Mitsuru, Schaedelin, Sabine, Piehl, Fredrik, Furlan, Roberto, Gastaldi, Matteo, Lambert, Jeremy, Evertsson, Björn, Fink, Katharina, Matsushita, Takuya, Masaki, Katsuhisa, Isobe, Noriko, Kira, Jun-Ichi, Benkert, Pascal, Maceski, Aleksandra, Willemse, Eline, Oechtering, Johanna, Orleth, Annette, Meier, Stephanie, & . (2023). Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 726–737. https://doi.org/10.1136/jnnp-2022-330796
Leppert, David, Watanabe, Mitsuru, Schaedelin, Sabine, Piehl, Fredrik, Furlan, Roberto, Gastaldi, Matteo, Lambert, Jeremy, Evertsson, Björn, Fink, Katharina, Matsushita, Takuya, Masaki, Katsuhisa, Isobe, Noriko, Kira, Jun-Ichi, Benkert, Pascal, Maceski, Aleksandra, Willemse, Eline, Oechtering, Johanna, Orleth, Annette, Meier, Stephanie, & . (2023). Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 726–737. https://doi.org/10.1136/jnnp-2022-330796
Saraste, Maija, Matilainen, Markus, Vuorimaa, Anna, Laaksonen, Sini, Sucksdorff, Marcus, Leppert, David, , & Airas, Laura. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 698–706. https://doi.org/10.1136/jnnp-2023-331051
Saraste, Maija, Matilainen, Markus, Vuorimaa, Anna, Laaksonen, Sini, Sucksdorff, Marcus, Leppert, David, , & Airas, Laura. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 698–706. https://doi.org/10.1136/jnnp-2023-331051
Todea, Alexandra Ramona, Melie-Garcia, Lester, Barakovic, Muhamed, Cagol, Alessandro, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Schaedelin, Sabine, Benkert, Pascal, Oezguer, Yaldizli, Sinnecker, Tim, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, et al. (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. Journal of Magnetic Resonance Imaging, 58(3), 864–876. https://doi.org/10.1002/jmri.28618
Todea, Alexandra Ramona, Melie-Garcia, Lester, Barakovic, Muhamed, Cagol, Alessandro, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Schaedelin, Sabine, Benkert, Pascal, Oezguer, Yaldizli, Sinnecker, Tim, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, et al. (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. Journal of Magnetic Resonance Imaging, 58(3), 864–876. https://doi.org/10.1002/jmri.28618
Roos, Izanne, Hughes, Stella, McDonnell, Gavin, Malpas, Charles B., Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, , Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, et al. (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(8), 789–797. https://doi.org/10.1001/jamaneurol.2023.1625
Roos, Izanne, Hughes, Stella, McDonnell, Gavin, Malpas, Charles B., Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, , Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, et al. (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(8), 789–797. https://doi.org/10.1001/jamaneurol.2023.1625
Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette, Soysal, Aysun, , Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L.A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, et al. (2023). A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry. Neurodegenerative Disease Management, 13(4), 215–221. https://doi.org/10.2217/nmt-2023-0005
Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette, Soysal, Aysun, , Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L.A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, et al. (2023). A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry. Neurodegenerative Disease Management, 13(4), 215–221. https://doi.org/10.2217/nmt-2023-0005
Kiss, Máté G., Mindur, John E., Yates, Abi G., Lee, Donghoon, Fullard, John F., Anzai, Atsushi, Poller, Wolfram C., Christie, Kathleen A., Iwamoto, Yoshiko, Roudko, Vladimir, Downey, Jeffrey, Chan, Christopher T., Huynh, Pacific, Janssen, Henrike, Ntranos, Achilles, Hoffmann, Jan D., Jacob, Walter, Goswami, Sukanya, Singh, Sumnima, et al. (2023). Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity, 56(7), 1502–1514. https://doi.org/10.1016/j.immuni.2023.04.013
Kiss, Máté G., Mindur, John E., Yates, Abi G., Lee, Donghoon, Fullard, John F., Anzai, Atsushi, Poller, Wolfram C., Christie, Kathleen A., Iwamoto, Yoshiko, Roudko, Vladimir, Downey, Jeffrey, Chan, Christopher T., Huynh, Pacific, Janssen, Henrike, Ntranos, Achilles, Hoffmann, Jan D., Jacob, Walter, Goswami, Sukanya, Singh, Sumnima, et al. (2023). Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity, 56(7), 1502–1514. https://doi.org/10.1016/j.immuni.2023.04.013
Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, MacDonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trněný, Marek, Kozak, Tomas, Van Der Walt, Anneke, et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(7), 702–713. https://doi.org/10.1001/jamaneurol.2023.1184
Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, MacDonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trněný, Marek, Kozak, Tomas, Van Der Walt, Anneke, et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(7), 702–713. https://doi.org/10.1001/jamaneurol.2023.1184
Zhu, Chao, Kalincik, Tomas, Horakova, Dana, Zhou, Zhen, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, , Patti, Francesco, Grand’maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, et al. (2023). Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation. JAMA Neurology, 80(7), 739–748. https://doi.org/10.1001/jamaneurol.2023.1542
Zhu, Chao, Kalincik, Tomas, Horakova, Dana, Zhou, Zhen, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, , Patti, Francesco, Grand’maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, et al. (2023). Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation. JAMA Neurology, 80(7), 739–748. https://doi.org/10.1001/jamaneurol.2023.1542
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, , Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, , Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, , Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials [Journal-article]. eBioMedicine, 93, 104662. https://doi.org/10.1016/j.ebiom.2023.104662
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, , Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials [Journal-article]. eBioMedicine, 93, 104662. https://doi.org/10.1016/j.ebiom.2023.104662
Bavato, Francesco, Kexel, Ann-Kathrin, Kluwe-Schiavon, Bruno, Maceski, Aleksandra, Baumgartner, Markus R., Seifritz, Erich, , & Quednow, Boris B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users. Molecular Neurobiology, 60(7), 3935–3944. https://doi.org/10.1007/s12035-023-03327-6
Bavato, Francesco, Kexel, Ann-Kathrin, Kluwe-Schiavon, Bruno, Maceski, Aleksandra, Baumgartner, Markus R., Seifritz, Erich, , & Quednow, Boris B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users. Molecular Neurobiology, 60(7), 3935–3944. https://doi.org/10.1007/s12035-023-03327-6
Brousse, Mehdi, Delaby, Constance, De La Cruz, Elisa, , Benkert, Pascal, Mondesert, Etienne, Ginestet, Nelly, Hirtz, Christophe, Camu, William, Lehmann, Sylvain, & Esselin, Florence. (2023). Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology, 30(7), 1919–1927. https://doi.org/10.1111/ene.15813
Brousse, Mehdi, Delaby, Constance, De La Cruz, Elisa, , Benkert, Pascal, Mondesert, Etienne, Ginestet, Nelly, Hirtz, Christophe, Camu, William, Lehmann, Sylvain, & Esselin, Florence. (2023). Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology, 30(7), 1919–1927. https://doi.org/10.1111/ene.15813
Geis, Tobias, Gutzeit, Svena, Fouzas, Sotiris, Ambrosch, Andreas, Benkert, Pascal, , & Wellmann, Sven. (2023). Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases. European Journal of Paediatric Neurology, 45, 9–13. https://doi.org/10.1016/j.ejpn.2023.05.003
Geis, Tobias, Gutzeit, Svena, Fouzas, Sotiris, Ambrosch, Andreas, Benkert, Pascal, , & Wellmann, Sven. (2023). Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases. European Journal of Paediatric Neurology, 45, 9–13. https://doi.org/10.1016/j.ejpn.2023.05.003
Telser, Julia, Grossmann, Kirsten, Weideli, Ornella C., Hillmann, Dorothea, Aeschbacher, Stefanie, Wohlwend, Niklas, Velez, Laura, , Maleska, Aleksandra, Benkert, Pascal, Risch, Corina, Conen, David, Risch, Martin, & Risch, Lorenz. (2023). Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study. Diagnostics, 13(13). https://doi.org/10.3390/diagnostics13132167
Telser, Julia, Grossmann, Kirsten, Weideli, Ornella C., Hillmann, Dorothea, Aeschbacher, Stefanie, Wohlwend, Niklas, Velez, Laura, , Maleska, Aleksandra, Benkert, Pascal, Risch, Corina, Conen, David, Risch, Martin, & Risch, Lorenz. (2023). Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study. Diagnostics, 13(13). https://doi.org/10.3390/diagnostics13132167
Abdelhak, Ahmed, , & Green, Ari J. (2023). Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain. JAMA Neurology, 80(6), 542–543. https://doi.org/10.1001/jamaneurol.2023.0394
Abdelhak, Ahmed, , & Green, Ari J. (2023). Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain. JAMA Neurology, 80(6), 542–543. https://doi.org/10.1001/jamaneurol.2023.0394
Andreasson U, Gobom J, Delatour V, Auclair G, Noam Y, Lee S, Wen J, Jeromin A, Arslan B, Maceski A, Willemse E, Zetterberg H, , & Blennow K. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Clinical Chemistry and Laboratory Medicine, 61(7), 1245–1254. https://doi.org/10.1515/cclm-2022-1181
Andreasson U, Gobom J, Delatour V, Auclair G, Noam Y, Lee S, Wen J, Jeromin A, Arslan B, Maceski A, Willemse E, Zetterberg H, , & Blennow K. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Clinical Chemistry and Laboratory Medicine, 61(7), 1245–1254. https://doi.org/10.1515/cclm-2022-1181
Daruwalla, Cyrus, Shaygannejad, Vahid, Ozakbas, Serkan, Havrdova, Eva Kubala, Horakova, Dana, Alroughani, Raed, Boz, Cavit, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J, Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, et al. (2023). Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 29(7), 875–883. https://doi.org/10.1177/13524585231151951
Daruwalla, Cyrus, Shaygannejad, Vahid, Ozakbas, Serkan, Havrdova, Eva Kubala, Horakova, Dana, Alroughani, Raed, Boz, Cavit, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J, Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, et al. (2023). Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 29(7), 875–883. https://doi.org/10.1177/13524585231151951
Ziaei, Amin, Nasr, Zahra, Hart, Janace, Francisco, Carla, Rutatangwa, Alice, Leppert, David, , Flanagan, Eoin, & Waubant, Emmanuelle. (2023). High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases. Multiple Sclerosis and Related Disorders, 74. https://doi.org/10.1016/j.msard.2023.104704
Ziaei, Amin, Nasr, Zahra, Hart, Janace, Francisco, Carla, Rutatangwa, Alice, Leppert, David, , Flanagan, Eoin, & Waubant, Emmanuelle. (2023). High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases. Multiple Sclerosis and Related Disorders, 74. https://doi.org/10.1016/j.msard.2023.104704
Buchmann, Arabella, Pirpamer, Lukas, Pinter, Daniela, Voortman, Margarete, Helmlinger, Birgit, Pichler, Alexander, Maceski, Aleksandra Maleska, Benkert, Pascal, Bachmaier, Gerhard, Ropele, Stefan, Reindl, Markus, Leppert, David, , Enzinger, Christian, & Khalil, Michael. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology, 30(5), 1389–1399. https://doi.org/10.1111/ene.15742
Buchmann, Arabella, Pirpamer, Lukas, Pinter, Daniela, Voortman, Margarete, Helmlinger, Birgit, Pichler, Alexander, Maceski, Aleksandra Maleska, Benkert, Pascal, Bachmaier, Gerhard, Ropele, Stefan, Reindl, Markus, Leppert, David, , Enzinger, Christian, & Khalil, Michael. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology, 30(5), 1389–1399. https://doi.org/10.1111/ene.15742
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, , Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, , Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, , Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis [Journal-article]. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, , Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis [Journal-article]. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, , Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, , Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
Margraf NG, Dargvainiene J, Theel E, Leypoldt F, Lieb W, Franke A, Berger K, , & Kuhlenbaeumer G. (2023). Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus. Journal of Neurology, 270(4), 2128–2138. https://doi.org/10.1007/s00415-022-11547-4
Margraf NG, Dargvainiene J, Theel E, Leypoldt F, Lieb W, Franke A, Berger K, , & Kuhlenbaeumer G. (2023). Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus. Journal of Neurology, 270(4), 2128–2138. https://doi.org/10.1007/s00415-022-11547-4
Nittas, Vasileios, Zecca, Chiara, Kamm, Christian P., , Chan, Andrew, & Wyl, Viktor Von. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLoS ONE, 18(4 APRIL). https://doi.org/10.1371/journal.pone.0284477
Nittas, Vasileios, Zecca, Chiara, Kamm, Christian P., , Chan, Andrew, & Wyl, Viktor Von. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLoS ONE, 18(4 APRIL). https://doi.org/10.1371/journal.pone.0284477
Theil, Diethilde, , Brees, Dominique, Tritto, Elaine, Pognan, François, Frieauff, Wilfried, Penraat, Kelley, Meseck, Emily, Valdez, Reginald, & Hartmann, Andreas. (2023). Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity. Toxicologic Pathology, 51(3), 135–147. https://doi.org/10.1177/01926233231180179
Theil, Diethilde, , Brees, Dominique, Tritto, Elaine, Pognan, François, Frieauff, Wilfried, Penraat, Kelley, Meseck, Emily, Valdez, Reginald, & Hartmann, Andreas. (2023). Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity. Toxicologic Pathology, 51(3), 135–147. https://doi.org/10.1177/01926233231180179
Vermunt, L., Sutphen, C., Dicks, E., de Leeuw, D. M., Allegri, R., Berman, S. B., Cash, D. M., Chhatwal, J. P., Cruchaga, C., Day, G., Ewers, M., Farlow, M., Fox, N. C., Ghetti, B., Graff-Radford, N., Hassenstab, J., Jucker, M., Karch, C. M., , et al. (2023). Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.21.23287468
Vermunt, L., Sutphen, C., Dicks, E., de Leeuw, D. M., Allegri, R., Berman, S. B., Cash, D. M., Chhatwal, J. P., Cruchaga, C., Day, G., Ewers, M., Farlow, M., Fox, N. C., Ghetti, B., Graff-Radford, N., Hassenstab, J., Jucker, M., Karch, C. M., , et al. (2023). Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.21.23287468